SCHEMBL29879197

SCHEMBL29879197

Nc1cc(Cc2cn3cc(C4CC4)ccc3n2)ncn1

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 1/20 0.40
▸ KLKB1 P03952 19/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29174241 1.00 METTL3 (0.40) METTL3KLKB1
SCHEMBL30711698 0.83 KLKB1 (0.41) METTL3KLKB1
SCHEMBL24738257 0.82 METTL3 (0.39) METTL3KLKB1
SCHEMBL29926787 0.81 METTL3 (0.44) METTL3KLKB1
SCHEMBL24729484 0.81 METTL3 (0.44) METTL3KLKB1
SCHEMBL29879407 0.78 METTL3 (0.44) METTL3KLKB1
SCHEMBL29303134 0.78 METTL3 (0.44) METTL3KLKB1
SCHEMBL29141751 0.76 METTL3 (0.48) METTL3KLKB1
SCHEMBL21368346 0.76 METTL3 (0.45) METTL3KLKB1
SCHEMBL24729569 0.75 METTL3 (0.39) METTL3KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308230-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
CN-117396474-A Plasma kallikrein inhibitors 武田药品工业株式会社 2024-01-12 — — CN disclosed
WO-2022197758-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback